

1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Dec 20, 2024 accepted 8:00 AM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 10, 2024 accepted 4:41 PM ET | ELDNEledon Pharmaceuticals, Inc. | Officer / director change |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Oct 2, 2023 accepted 7:30 AM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 21, 2023 accepted 7:09 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 13, 2023 accepted 4:42 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 22, 2023 accepted 7:51 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change5.07Shareholder vote | DocumentSEC ↗ |
May 1, 2023 accepted 7:27 AM ET | ELDNEledon Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 2, 2021 accepted 9:00 AM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 2, 2021 accepted 8:30 AM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 15, 2021 accepted 2:00 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 15, 2020 accepted 5:19 PM ET | ELDNEledon Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 4, 2020 accepted 4:25 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 17, 2020 accepted 4:05 PM ET | ELDNEledon Pharmaceuticals, Inc. | 2.05Restructuring costs5.02Officer / director change | DocumentSEC ↗ |
Jul 12, 2019 accepted 4:05 PM ET | ELDNEledon Pharmaceuticals, Inc. | 4.01Auditor change5.02Officer / director change | DocumentSEC ↗ |
Nov 6, 2017 accepted 4:30 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 10, 2017 accepted 5:21 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 31, 2017 accepted 4:05 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 15, 2017 accepted 4:23 PM ET | ELDNEledon Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale3.03Holder rights modified4.01Auditor change5.02Officer / director change5.03Bylaws / fiscal year5.07Shareholder vote | DocumentSEC ↗ |
Oct 12, 2016 accepted 4:07 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 3, 2016 accepted 7:53 AM ET | ELDNEledon Pharmaceuticals, Inc. | 2.05Restructuring costs5.02Officer / director change | DocumentSEC ↗ |
May 31, 2016 accepted 7:12 AM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 15, 2015 accepted 4:30 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jan 9, 2015 accepted 8:30 AM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Oct 17, 2014 accepted 5:00 PM ET | ELDNEledon Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |